Total Payments
$5,616
2024 Payments
$969.84
Companies
22
Transactions
134
Medicare Patients
2,765
Medicare Billing
$235,258
Payment Breakdown by Category
Food & Beverage$4,200 (74.8%)
Travel$1,267 (22.6%)
Other$150.00 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,200 | 130 | 74.8% |
| Travel and Lodging | $1,267 | 3 | 22.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $1,300 | 12 | $0 (2023) |
| ABBVIE INC. | $1,168 | 57 | $0 (2024) |
| TissueTech, Inc. | $927.81 | 14 | $0 (2018) |
| NotalVision | $326.51 | 2 | $0 (2018) |
| Alcon Vision LLC | $324.00 | 5 | $0 (2022) |
| Shire North American Group Inc | $280.43 | 4 | $0 (2018) |
| BIOTISSUE HOLDINGS INC. | $253.96 | 4 | $0 (2024) |
| Allergan, Inc. | $209.70 | 6 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $134.72 | 6 | $0 (2023) |
| Dompe US, Inc. | $130.10 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $969.84 | 28 | ABBVIE INC. ($444.43) |
| 2023 | $994.07 | 38 | AbbVie Inc. ($517.17) |
| 2022 | $629.65 | 23 | ABBVIE INC. ($206.37) |
| 2021 | $208.78 | 8 | Allergan, Inc. ($75.90) |
| 2020 | $139.26 | 2 | Alcon Vision LLC ($119.76) |
| 2019 | $1,011 | 10 | Johnson & Johnson Surgical Vision, Inc. ($962.20) |
| 2018 | $606.52 | 8 | NotalVision ($326.51) |
| 2017 | $1,057 | 17 | TissueTech, Inc. ($916.29) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: EYE CARE | ||||||
| 09/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: EYE CARE | ||||||
| 08/16/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: EYE CARE | ||||||
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $209.09 | General |
| 05/12/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $4.61 | General |
| 04/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.56 | General |
| 04/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/19/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: OPTOMETRY | ||||||
| 04/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: EYE CARE | ||||||
| 04/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: EYE CARE | ||||||
| 04/15/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 04/10/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: SOLUTION/ DROPS | ||||||
| 04/05/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $26.21 | General |
| Category: Corneal Health | ||||||
| 03/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: EYE CARE | ||||||
| 03/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: EYE CARE | ||||||
| 03/18/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 03/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.57 | General |
| 03/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.16 | General |
| 03/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Dry eyes | ||||||
| 03/01/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: EYE CARE | ||||||
| 02/23/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $33.05 | General |
| 02/19/2024 | Bausch & Lomb Americas Inc. | ALDEN SCLERAL ZENLENS (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Ophthalmology | ||||||
| 02/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: EYE CARE | ||||||
| 01/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: EYE CARE | ||||||
| 01/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 371 | 455 | $116,704 | $37,664 |
| 2022 | 10 | 313 | 387 | $95,526 | $31,911 |
| 2021 | 17 | 1,237 | 1,616 | $285,306 | $100,550 |
| 2020 | 14 | 844 | 1,016 | $169,036 | $65,133 |
Total Patients
2,765
Total Services
3,474
Medicare Billing
$235,258
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 127 | $38,227 | $13,416 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 78 | $16,614 | $5,400 | 32.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 60 | 63 | $18,900 | $5,360 | 28.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 13 | 17 | $10,440 | $2,914 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,208 | $2,120 | 34.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 21 | 21 | $7,455 | $2,002 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 37 | $4,884 | $1,735 | 35.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 23 | 27 | $4,131 | $1,494 | 36.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $2,568 | $987.24 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,144 | $930.00 | 29.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 29 | 29 | $2,581 | $755.96 | 29.3% |
| 92134 | Imaging of retina | Office | 2023 | 15 | 16 | $1,552 | $549.42 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 127 | $27,051 | $9,937 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 55 | $16,555 | $5,485 | 33.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 52 | 55 | $16,555 | $5,455 | 33.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 36 | 36 | $12,780 | $3,579 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,760 | $2,295 | 29.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 19 | 20 | $4,280 | $1,651 | 38.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 16 | 18 | $2,754 | $1,076 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,144 | $906.18 | 28.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 25 | 27 | $2,403 | $821.99 | 34.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 17 | $2,244 | $704.11 | 31.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 271 | 403 | $61,858 | $24,866 | 40.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 208 | 209 | $40,260 | $17,965 | 44.6% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 20 | 30 | $60,000 | $13,104 | 21.8% |
About Dr. Gitanjali Baveja, MD
Dr. Gitanjali Baveja, MD is a Ophthalmology healthcare provider based in Mc Lean, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164563946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gitanjali Baveja, MD has received a total of $5,616 in payments from pharmaceutical and medical device companies, with $969.84 received in 2024. These payments were reported across 134 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,200).
As a Medicare-enrolled provider, Baveja has provided services to 2,765 Medicare beneficiaries, totaling 3,474 services with total Medicare billing of $235,258. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Mc Lean, VA
- Active Since 02/12/2007
- Last Updated 09/28/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1164563946
Products in Payments
- Prokera (Device) $927.81
- TearScience Lipiflow System (Device) $927.65
- LUMIGAN (Drug) $460.81
- VUITY (Drug) $407.24
- ForeseeHome (Device) $326.51
- DURYSTA (Drug) $230.54
- XIIDRA (Drug) $183.82
- Tecnis IOL (Device) $168.12
- Clareon (Device) $159.86
- TECNIS IOL (Device) $150.00
- ReSTOR (Device) $147.18
- OXERVATE (Drug) $130.10
- Cequa (Drug) $94.22
- RESTASIS MULTIDOSE (Drug) $75.90
- RXSIGHT CONTACT LENS (Device) $65.63
- INVELTYS (Drug) $55.38
- TYRVAYA (Drug) $37.19
- RESTASIS (Drug) $28.24
- CE-marked KXLA system (Device) $26.21
- VEVYE (Drug) $25.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Mc Lean
Dr. Rajesh Rajpal, M.d, M.D
Ophthalmology — Payments: $131,959
Ophthalmology $131,959
Kim Jiramongkolchai, Md, MD
Ophthalmology — Payments: $21,036
Ophthalmology $21,036
Dr. Anne Schwartz, M.d, M.D
Ophthalmology — Payments: $4,433
Ophthalmology $4,433
Andrew Holzman, M.d, M.D
Ophthalmology — Payments: $3,774
Ophthalmology $3,774
Mr. Michael Tigani, Md, MD
Ophthalmology — Payments: $3,369
Ophthalmology $3,369
Soraiya Thura, Md, MD
Ophthalmology — Payments: $3,246
Ophthalmology $3,246